期刊文献+

地西泮固体脂质纳米粒的制备及大鼠经鼻腔给药的药动学研究 被引量:13

Preparation of Diazepam Solid Lipid Nanoparticles and Its Pharmacokinetics after Intranasal Administration in Rats
原文传递
导出
摘要 目的制备地西泮固体脂质纳米粒,评价其制剂学性质,并探讨其经鼻腔给药后的药动学过程。方法用高温乳化-低温固化法制备地西泮固体脂质纳米粒,考察了其包封率、体外释药、粒径分布、Zeta电位和形态;大鼠经鼻腔给予固体脂质纳米粒或静脉给予地西泮注射液后经股动脉插管采集血样,采用HPLC测定血药浓度,以DAS1.0软件估算药动学参数。结果制备的地西泮固体脂质纳米粒形态为类球形,平均粒径为(104.4±0.56)nm;Zeta电位为(-18.50±0.98)mV;包封率为(98.8±3)%。经鼻腔给药后,地西泮固体脂质纳米粒的tmax为11 min,ρmax为(0.33±0.01)μg.mL-1,绝对生物利用度为67.01%。结论鼻腔给予地西泮固体脂质纳米粒后吸收迅速,绝对生物利用度较高,有望成为治疗癫痫持续状态的新型制剂。 OBJECTIVE To prepare diazepam solid lipid nanoparticles,evaluate the pharmacy characters and study the pharmacokinetics after intranasal administration.METHODS Diazepam solid lipid nanoparticles were prepared by high temperature emulsification-low temperature solidification method.The entrapment efficiency,particle size distrubtion,Zeta potential and morphology were measured.After administrating solid lipid nanoparticles in intranasal routes or diazepam parenteral solution via intravenous,the blood samples were collected from the femoral artery.Drug concentration in plasma were analyzed by HPLC method.The concentration-time curves were obtained,and pharmacokinetic parameters were obtained by DAS 1.0.RESULTS The morphology of diazepam solid lipid nanoparticles obtained were appoximately spherical.The average particle size was(104.4±0.56) nm.The Zeta potential was(-18.50±0.98) mV.Encapsulating efficiency was(98.8±3)%.After intranasal aministration of diazepam solid lipid nanoparticles,tmax was 11 min,ρmax was(0.33±0.01) μg·mL^-1,and the absolute bioavailability was 67.01%.CONCLUSION The rapid absorption and high absolute bioavailability were obtained after nasal administration of diazepam solid lipid nanoparticle.It is a promising approach for the treatment of status epilepticus.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第1期44-47,共4页 Chinese Pharmaceutical Journal
关键词 地西泮 固体脂质纳米粒 鼻腔给药 diazepam solid lipid nanoparticles intranasal
  • 相关文献

参考文献9

  • 1TREIMAN D M. Generalized convulsive status epilepticus in the adult[ J]. Epilepsia,1993,34 ( Suppl. 1 ) :2-11. 被引量:1
  • 2LOTT R S. Seizure disorders. In: Koda-Kimble,A. M. (Ed.), Applied Therapeutics : The Clinical Use of Drugs. Washington : Applied Therapeutics, Inc, 1993 : 1369-1396. 被引量:1
  • 3LI L, GORUKANTI S, CHOI Y M,et al. Rapid-onset intranasal delivery of anticonvulsants : pharmacokinetic and pharmacodynamic evaluation in rabbits[J]. Int J Pharm, 2000, 199( 1 ) :65-76. 被引量:1
  • 4王东兴,高永良.鼻腔给药新剂型研究进展[J].中国新药杂志,2002,11(8):589-592. 被引量:34
  • 5CAVALLI R, BARGONI A, CAPUTO O, et al. Transmucosal transport of tobramycin incorporated in solid lipid nanospheres (SLN) after duodenal administration to rats-part I: pharmacokinetics[ J]. Pharmacol Res ,2000 , 42 : 541-545. 被引量:1
  • 6MEHNERT W, MADER K. Solid lipid nanoparticles--production,characterization and applications [ J ]. Adv Drug Deliv Rev, 2001, 47(2-3) :165-196. 被引量:1
  • 7MULLER R H, MADER K, GOHLA S. Solid lipid nanopartieles ( SLN ) for controlled drug delivery--a review of the state of the art [J]. Eur J Pharrn Biopharm,2000,50( 1 ) :161-177. 被引量:1
  • 8王峰,蒋新国.鼻粘膜作为脑内递药途径的研究进展[J].药学学报,2001,36(8):636-640. 被引量:24
  • 9ILI,UM L. Transport of drugs from the nasal cavity to the central nervous system[ J]. Eur J Pharm Sci ,2000,11 ( 1 ) : 1-18. 被引量:1

二级参考文献41

  • 1董泽民.赖氨匹林脂质体鼻腔给药的研究[J].中国医药工业杂志,1995,26(5):199-202. 被引量:18
  • 2Chow H S,J Pharm Sci,1999年,88卷,8期,754页 被引量:1
  • 3Wang Y,Biopharm Drug Dispos,1998年,19卷,9期,571页 被引量:1
  • 4Chou K J,Int J Pharm,1998年,168卷,2期,137页 被引量:1
  • 5Chou K J,Int J Pharm,1998年,171卷,1期,53页 被引量:1
  • 6Chou K J,Biopharm Drug Dispos,1997年,18卷,4期,335页 被引量:1
  • 7Frey W H,Drug Deliv J Deliv Targeting Ther Agents,1997年,4卷,2期,87页 被引量:1
  • 8Behl CR,Pimplaskar HK,Sileno AP,et al.Effects of physicochemical properties and other factors on systemic nasal drug delivery[J].Adv Drug Deliv Rev,1998,29(1-2)∶89-116. 被引量:1
  • 9Chien-Hua Niu,Yuan-Yuan Chiu.FDA perspective on peptide formulation and stability issues[J].J Pharm Sci,1998,87(11)∶1331-1334. 被引量:1
  • 10Varsha A,Mishra B.Recent trends in drug delivery systems:intranasal drug delivery[J].Indian J Exp Bio,1999,37(1)∶6-16. 被引量:1

共引文献52

同被引文献178

引证文献13

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部